http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107540747-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 |
| filingDate | 2017-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107540747-B |
| titleOfInvention | Anti-human DLL4 monoclonal antibody 6F12 |
| abstract | The invention discloses an anti-human DLL4 monoclonal antibody 6F12, which is secreted by a hybridoma cell strain, wherein the preservation information of the hybridoma cell strain is as follows: the preservation unit: china general microbiological culture Collection center (CGMCC), preservation address: xilu No.1 Hospital No. 3, Beijing, Chaoyang, North; preservation time: 6 months and 7 days 2017; the preservation number is as follows: CGMCC No. 14284; and (3) classification and naming: and (3) a hybridoma cell strain 6F12 secreting an anti-human DLL4 molecular monoclonal antibody. Binding of monoclonal antibody 6F12 of the invention to DCs did not block the ability of DLL4+ DCs to induce meive T cells to differentiate in the Th1 direction compared to commercial clone MHD 4-46. |
| priorityDate | 2017-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 237.